Mariner, LLC

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1373442 Overland Park, KS

Position in SRPT

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$4,781,172

-$751,383 QoQ

Shares Held

219,723

-14.5% QoQ

Ownership

0.208%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Mariner, LLC holds $324,140,503 across 135 Biotechnology names. SRPT ranks #13 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	123,954	$95,771,817
2	VRTX	Vertex Pharmaceuticals Inc / Ma	131,600	$58,764,661
3	TERN	Terns Pharmaceuticals, Inc.	557,361	$29,384,071
4	BMRN	Biomarin Pharmaceutical Inc	268,901	$15,190,217
5	EXEL	Exelixis, Inc.	307,928	$13,207,031
6	INCY	Incyte Corp	121,091	$11,397,084
7	ALNY	Alnylam Pharmaceuticals, Inc.	29,948	$9,908,894
8	JAZZ	Jazz Pharmaceuticals plc	40,016	$7,565,024

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,781,172	219,723	-14.5%	Shares	Sole	2026-05-13
2025-12-31	$5,532,555	257,089	+373.5%	Shares	Sole	2026-02-13
2025-09-30	$1,046,168	54,290	+627.8%	Shares	Sole	2025-11-14
2025-03-31	$476,033	7,459	-7.2%	Shares	Sole	2025-05-15
2024-12-31	$977,826	8,042	+14.8%	Shares	Sole	2025-02-13
2024-09-30	$875,104	7,007	+2.4%	Shares	Sole	2024-11-13
2024-06-30	$1,081,352	6,844	+9.8%	Shares	Sole	2024-08-13
2024-03-31	$806,665	6,231	+7.6%	Shares	Sole	2024-05-15
2023-12-31	$558,522	5,792	+91.5%	Shares	Sole	2024-02-14
2023-09-30	$366,690	3,025	-6.0%	Shares	Sole	2023-11-13
2023-06-30	$368,410	3,217	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.